We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+19.44%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$16.3B
AUM Growth
+$2.23B
Cap. Flow
+$11.5M
Cap. Flow %
0.07%
Top 10 Hldgs %
28.95%
Holding
925
New
168
Increased
172
Reduced
404
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 25.96%
2 Healthcare 17.04%
3 Financials 14.51%
4 Consumer Discretionary 9.44%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDD icon
276
Pinduoduo
PDD
$130B
$5.74M 0.04%
+32,300
New +$3.86M
SCS
277
DELISTED
Steelcase
SCS
$5.5M 0.03%
406,297
-278,500
-41% -$3.41M
QIWI
278
DELISTED
QIWI PLC
QIWI
$5.49M 0.03%
533,420
+85,700
+19% +$1.24M
CVSA
279
Covista Inc
CVSA
$4.42B
$5.49M 0.03%
161,700
-74,400
-32% -$2.12M
AMCX icon
280
AMC Global Media
AMCX
$501M
$5.48M 0.03%
153,300
+106,100
+225% +$2.97M
SCL icon
281
Stepan Co
SCL
$1.45B
$5.44M 0.03%
45,603
-36,400
-44% -$4.29M
INTU icon
282
Intuit
INTU
$88.5B
$5.44M 0.03%
14,315
-7,084
-33% -$2.49M
ETD icon
283
Ethan Allen Interiors
ETD
$608M
$5.36M 0.03%
265,400
-228,200
-46% -$4.02M
SPG icon
284
Simon Property Group
SPG
$73.3B
$5.24M 0.03%
61,477
-7,890
-11% -$602K
IBN icon
285
ICICI Bank
IBN
$109B
$5.22M 0.03%
351,500
+326,000
+1,278% +$4.1M
PCG icon
286
PG&E
PCG
$38.4B
$5.17M 0.03%
415,154
-370
-0.1% -$4.19K
IOSP icon
287
Innospec
IOSP
$2.14B
$5.16M 0.03%
56,869
-178,805
-76% -$13.9M
VVX icon
288
V2X
VVX
$2.47B
$5.1M 0.03%
102,600
-121,557
-54% -$5.44M
BKR icon
289
Baker Hughes
BKR
$61.3B
$5.07M 0.03%
243,211
+132,571
+120% +$2.33M
ZUMZ icon
290
Zumiez
ZUMZ
$336M
$4.98M 0.03%
135,300
-80,800
-37% -$2.72M
MTOR
291
DELISTED
MERITOR, Inc.
MTOR
$4.95M 0.03%
177,400
-225,200
-56% -$5.95M
ENS icon
292
EnerSys
ENS
$7.06B
$4.94M 0.03%
59,500
+4,400
+8% +$345K
EBAY icon
293
eBay
EBAY
$48.7B
$4.9M 0.03%
97,505
-100,158
-51% -$5.11M
VIVO
294
DELISTED
Meridian Bioscience Inc
VIVO
$4.88M 0.03%
261,100
-154,600
-37% -$2.89M
SRI icon
295
Stoneridge
SRI
$213M
$4.87M 0.03%
161,000
-152,200
-49% -$3.94M
REG icon
296
Regency Centers
REG
$14.5B
$4.81M 0.03%
105,575
SEM
297
DELISTED
Select Medical
SEM
$4.8M 0.03%
322,016
-113,958
-26% -$1.49M
CTB
298
DELISTED
Cooper Tire & Rubber Co.
CTB
$4.79M 0.03%
118,300
-5,100
-4% -$194K
SYKE
299
DELISTED
SYKES Enterprises Inc
SYKE
$4.76M 0.03%
126,413
-189,500
-60% -$7.07M
BMY icon
300
Bristol-Myers Squibb
BMY
$135B
$4.72M 0.03%
76,091
-1,200
-2% -$73.8K

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2020 Portfolio in Review

As of Q4 2020, Grantham, Mayo, Van Otterloo & Co (GMO) held 925 positions worth $16.3B, up 16% from $14.1B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2020 filing shows 168 new, 172 increased, 404 reduced and 131 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 257,200 shares worth $96.5M. The largest sale was Philip Morris, an estimated $151M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2020 buy was iShares Core S&P 500 ETF: 257,200 shares worth $96.5M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Salesforce in Q4 2020, an estimated $84.7M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2020 reduction was Vipshop, cutting an estimated $64.7M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Philip Morris in Q4 2020, selling an estimated $151M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 29% of its $16.3B portfolio in Q4 2020.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 168 new positions and closed 131 in Q4 2020.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 16% quarter-over-quarter to $16.3B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2020, filed 12 Feb 2021.